Role of Bevacizumab as a prophylactic and rehabilitative treatment modality in cases of sporadic and syndromic vestibular schwannoma: Fifty shades of grey!-Reference-Cited by-同舟云学术

Role of Bevacizumab as a prophylactic and rehabilitative treatment modality in cases of sporadic and syndromic vestibular schwannoma: Fifty shades of grey!

Published:2020-03 Issue: Volume:19 Page:100607
ISSN:2214-7519
Container-title:Interdisciplinary Neurosurgery
language:en
Short-container-title:Interdisciplinary Neurosurgery

Author:

Tripathi Manjul,Deora Harsh,Kumar Narendra,Batish Aman,Dutta Pinaki,Gurnani Jenil,Mohindra Sandeep,Hussain Shahid Adnan,Kataria Ketan,Agrahari Abhinav,Singh Kataria Mandeep,Ahuja Chirag K.,Singh Paramjeet

Publisher

Elsevier BV

Subject

Clinical Neurology,Surgery

Reference16 articles.

1. Toxicity profile of bevacizumab in the UK neurofibromatosis type 2 cohort;Morris;J. Neurooncol.,2017

2. Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial;Xu;Int. J. Radiat. Oncol.,2018

3. Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation;Morris;Neuro-Oncol. Pract.,2016

4. Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients;Plotkin;Otol. Neurotol.,2010

5. Haplin C. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2;Plotkin;N. Engl. J. Med.,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Dimensional Imaging of Vestibular Schwannoma Reveals Distinctive Immunological Networks Across Histomorphic Niches inNF2-related Schwannomatosis;2024-04-12

2. PRIDE complex-like skin rash associated with bevacizumab;BMJ Case Reports;2022-07

3. Repeat gamma knife radiosurgery for cavernous sinus hemangiomas: A report of 3 cases;Interdisciplinary Neurosurgery;2021-09

4. Therapy of Sporadic and NF2-Related Vestibular Schwannoma;Cancers;2020-03-31

5. Methylprednisolone/prednisolone;Reactions Weekly;2019-12